iOmx Therapeutics
iOmx Therapeutics is a cancer Immunotherapy founded in 2016.
1
Funding Rounds
$150.3m
Money raised
Overview
iOmx Therapeutics is a cancer Immunotherapy founded in 2016.
- Website:
- Headquarters: Munich
- Social accounts: linkedin
Funding series
Funding Series Analysis
The company iOmx Therapeutics has raised a total of $75.26m in funding over 1 rounds.
Key Insights:
- iOmx Therapeutics Series B round, October 2021: $75.26m
iOmx Therapeutics Series B round, October 2021
$75.26m
Industries
iOmx Therapeutics is active in the following industries: